Procyanidins Boost the Neuroprotective Effect of Minocycline for Intracerebral Haemorrhage
Source abstract
Abstract
Abstract Poor prognosis is often expected after the treatment of intracerebral haemorrhage (ICH) when the approach lacks effective neuroprotective interventions. Minocycline (Mino) is a promising clinical neuroprotective candidate for acute ICH therapy that mainly inhibits activation of microglia/macrophages. However, to address iron neurotoxicity, ferroptosis, and oxidative stress‐induced multiple neuroinjury mechanisms, the neuroprotective effect of minocycline still urgently needs to be enhanced. To address this issue, procyanidins (PACs), typical natural polyphenols, is used to improve the neuroprotective effect of Mino by constructing PACs‐Mino nanoparticles (NPs) using 3‐aminophenylboronic acid as the crosslinker. The yielding NPs possessed improved antioxidant and iron‐removing capacities in vitro. More importantly, PACs‐Mino NPs exerted excellent therapeutic effects on ICH, showing improved neuroprotective activity and resulting in neurobehavioral recovery, in an in vitro cellular model and an in vivo ICH rat model. This study can provide a general strategy that uses natural polyphenols to boost the performance of drugs for ICH treatment, and the results may be further extended to other injuries of the central nervous system, such as brain injury and spinal cord injury.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Intracerebral and Subarachnoid Hemorrhage Research · Kruppel-like factors research · Acute Ischemic Stroke Management
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Neurosurgery West China Hospital Sichuan University Chengdu 610041 China
College of Polymer Science and Engineering State Key Laboratory of Polymer Materials Engineering Sichuan University Chengdu 610065 China
Funding
National Natural Science Foundation of China
References (61)
Show source-provided references
1. 10.1016/S0140-6736(18)31878-610.1016/S0140-6736(18)31878-6 ↗
2. 10.1016/S1474-4422(20)30364-110.1016/S1474-4422(20)30364-1 ↗
3. 10.1038/s41580-020-00324-810.1038/s41580-020-00324-8 ↗
4. 10.1002/adfm.20210143510.1002/adfm.202101435 ↗
5. 10.1093/brain/awz39310.1093/brain/awz393 ↗
6. 10.1021/acsami.1c0049110.1021/acsami.1c00491 ↗
7. 10.31635/ccschem.022.20210169610.31635/ccschem.022.202101696 ↗
8. 10.1002/smll.20220698210.1002/smll.202206982 ↗
9. 10.1002/glia.2300710.1002/glia.23007 ↗
10. 10.3389/fimmu.2022.84416310.3389/fimmu.2022.844163 ↗
11. 10.1016/j.bbi.2020.07.02710.1016/j.bbi.2020.07.027 ↗
12. 10.3389/fimmu.2022.91944410.3389/fimmu.2022.919444 ↗
13. 10.1016/j.jconrel.2020.02.00910.1016/j.jconrel.2020.02.009 ↗
14. 10.1021/acsnano.9b0582110.1021/acsnano.9b05821 ↗
15. 10.1038/nrd.2016.24810.1038/nrd.2016.248 ↗
16. 10.1039/D0MH01317J10.1039/D0MH01317J ↗
17. 10.1039/D1CS01165K10.1039/D1CS01165K ↗
18. 10.1002/adma.20200735610.1002/adma.202007356 ↗
19. 10.1002/advs.20190010110.1002/advs.201900101 ↗
20. 10.1016/j.biomaterials.2020.12062610.1016/j.biomaterials.2020.120626 ↗
21. Zhang J. · Adv. Mater. · 2023 · 35 · 11
22. Jia Z. J. · Adv. Funct. Mater. · 2021 · 31 · 14
23. 10.1039/D0CS00908C10.1039/D0CS00908C ↗
24. 10.1007/s10571-019-00691-710.1007/s10571-019-00691-7 ↗
25. 10.4103/1673-5374.19472210.4103/1673-5374.194722 ↗
26. 10.1021/acsami.2c0493010.1021/acsami.2c04930 ↗
27. 10.1002/smll.20210248510.1002/smll.202102485 ↗
28. 10.1016/j.biomaterials.2022.12190010.1016/j.biomaterials.2022.121900 ↗
29. Yang L. · Adv. Healthcare Mater. · 2022 · 11 · 12
30. 10.1002/advs.20210344410.1002/advs.202103444 ↗
31. Wei Z. W. · Adv. Funct. Mater. · 2020 · 30 · 49
32. Deng C. J. · Adv. Sci. · 2022 · 9 · 12
33. 10.1016/j.addr.2022.11462010.1016/j.addr.2022.114620 ↗
34. 10.1016/j.progpolymsci.2018.08.00510.1016/j.progpolymsci.2018.08.005 ↗
35. 10.1038/s42255-021-00491-810.1038/s42255-021-00491-8 ↗
36. 10.1016/j.freeradbiomed.2005.05.02410.1016/j.freeradbiomed.2005.05.024 ↗
37. 10.1016/j.foodchem.2021.12924110.1016/j.foodchem.2021.129241 ↗
38. 10.3390/molecules2710335710.3390/molecules27103357 ↗
39. 10.1016/j.scitotenv.2022.15886410.1016/j.scitotenv.2022.158864 ↗
40. 10.1021/acsami.1c2346110.1021/acsami.1c23461 ↗
41. 10.1038/nprot.2007.51310.1038/nprot.2007.513 ↗
42. 10.1016/S1474-4422(12)70104-710.1016/S1474-4422(12)70104-7 ↗
43. 10.1161/CIRCRESAHA.121.31994910.1161/CIRCRESAHA.121.319949 ↗
44. 10.3389/fimmu.2022.84724610.3389/fimmu.2022.847246 ↗
45. 10.1038/nature1193010.1038/nature11930 ↗
46. 10.1016/j.actbio.2021.03.03810.1016/j.actbio.2021.03.038 ↗
47. 10.1038/s41577-021-00508-z10.1038/s41577-021-00508-z ↗
48. 10.1126/science.aal353510.1126/science.aal3535 ↗
49. 10.1002/adfm.20221334210.1002/adfm.202213342 ↗
50. 10.1038/s41467-022-33015-310.1038/s41467-022-33015-3 ↗
51. Li J. J. · Adv. Mater. · 2022 · 34 · 46
52. Zhang L. · Adv. Mater. · 2022 · 34 · 30
53. 10.1136/svn-2018-00020510.1136/svn-2018-000205 ↗
54. 10.1038/s41583-020-0333-z10.1038/s41583-020-0333-z ↗
55. 10.1126/scitranslmed.abk013510.1126/scitranslmed.abk0135 ↗
56. 10.1038/s41593-017-0033-910.1038/s41593-017-0033-9 ↗
57. 10.1126/science.aba690510.1126/science.aba6905 ↗
58. 10.1038/s41586-022-05534-y10.1038/s41586-022-05534-y ↗
59. 10.3389/fneur.2021.66751110.3389/fneur.2021.667511 ↗
60. 10.1038/s41467-017-00770-710.1038/s41467-017-00770-7 ↗
61. 10.1016/j.carbpol.2016.11.00610.1016/j.carbpol.2016.11.006 ↗